Seres Therapeutics sets 2026 annual meeting for June 9

Seres Therapeutics, Inc.

Record date for voting is April 13, 2026; stockholders of record on that date are entitled to vote.
Rule 14a-8 stockholder proposals must be received by March 26, 2026, which is 10 days after this filing.
Definitive proxy statement will specify meeting time and location.
Meeting is scheduled more than 30 days after the 2025 annual meeting, triggering the revised proposal deadline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.